ARSArs Technica·5dBusiness
score-0.60
Shkreli cites biotech stock options as strategy during FTC's review of pharma ban violation
Original
Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says
“Emphasizes blatant legal defiance and individual arrogance, framing the story as a scandal of regulatory failure and personal misconduct.”